Indication for central vagal endorphinergic control of heart rate in dogs.

[1]  M. Laubie,et al.  Action of the morphinometic agent, fentanyl, on the nucleas tractus solitarii and the nucleus ambiguus cardiovascular neurons. , 1980, European journal of pharmacology.

[2]  J. Rotrosen,et al.  Enkephalin inactivation by N-terminal tyrosine cleavage: purification and partial characterization of a highly specific enzyme from human brain. , 1980, Life sciences.

[3]  T. Yaksh,et al.  Release of methionine-enkephalin immunoreactivity from the rat spinal cord in vivo. , 1980, European journal of pharmacology.

[4]  C. Pinsky,et al.  Effects of morphine and naloxone on the K+-stimulated release of methionine-enkephalin from slices of rat corpus striatum , 1980, Brain Research.

[5]  H. Y. Yang,et al.  Inhibition of in situ metabolism of [3H](met5)-enkephalin and potentiation of (met5)-enkephalin analgesia by captopril , 1980, Brain Research.

[6]  A. Karczmar,et al.  Di-isopropyl phosphofluoridate-induced antinociception: possible role of endogenous opioids. , 1980, European journal of pharmacology.

[7]  S. Snyder,et al.  Two distinct enkephalinases: solubilization, partial purification and separation from angiotensin converting enzyme. , 1979, Life sciences.

[8]  B. Pomeranz,et al.  Correlation of genetic differences in endorphin systems with analgesic effects of D-amino acids in mice , 1979, Brain Research.

[9]  H. Ueda,et al.  A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser , 1979, Nature.

[10]  M. Laubie,et al.  Vagal bradycardia produced by microinjections of morphine-like drugs into the nucleus ambiguus in anaesthetized dogs. , 1979, European journal of pharmacology.

[11]  R. Perdrisot,et al.  Inhibitory potency of various peptides on enkephalinase activity from mouse striatum. , 1979, Biochemical and biophysical research communications.

[12]  L. Iversen,et al.  Separation of human brain angiotensin-converting enzyme from enkephalin-degrading activity. , 1979, European journal of pharmacology.

[13]  R. Perdrisot,et al.  'Enkephalinase' is distinct from brain 'angiotensin-converting enzyme'. , 1979, European journal of pharmacology.

[14]  H. Ueda,et al.  Morphine-like analgesia by a new dipeptide, L-tyrosyl-L-arginine (Kyotorphin) and its analogue. , 1979, European journal of pharmacology.

[15]  J. Schwartz,et al.  Regional distribution of a high-affinity enkephalin-degrading peptidase (‘enkephalinase’) and effects of lesions suggest localization in the vicinity of opiate receptors in brain , 1979, Neuroscience Letters.

[16]  J. Schwartz,et al.  High-affinity enkephalin-degrading peptidase in brain is increased after morphine , 1978, Nature.

[17]  J. Holaday,et al.  Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock , 1978, Nature.

[18]  M. Knight,et al.  The relationship between enkephalin degradation and opiate receptor occupancy. , 1978, The Journal of biological chemistry.

[19]  K. Fuxe,et al.  Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats. , 1978, European journal of pharmacology.

[20]  A. Herz,et al.  Potassium-induced release of enkephalins from rat striatal slices. , 1978, European journal of pharmacology.

[21]  E. G. Erdös,et al.  Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. , 1978, Biochemical pharmacology.

[22]  F. Bloom,et al.  Release of enkephalin from rat globus pallidus in vitro , 1978, Nature.

[23]  G. Henderson,et al.  In vitro release of Leu- and Met-enkephalin from the corpus striatum , 1978, Nature.

[24]  M. Laubie,et al.  Central cardiovascular effects of morphinomimetic peptides in dogs. , 1977, European journal of pharmacology.

[25]  J. Meek,et al.  Enkephalin catabolism in vitro and in vivo , 1977, Neuropharmacology.

[26]  T. Hökfelt,et al.  Immunohistochemical studies using antibodies to leucine-enkephalin: Initial observations on the nervous system of the rat , 1976, Neuroscience.

[27]  J. Hughes,et al.  Some thoughts on the significance of enkephalin, the endogenous ligand. , 1975, Life sciences.

[28]  M. Laubie,et al.  Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. , 1974, European journal of pharmacology.

[29]  J. Kennedy,et al.  Narcotic-antagonist analgesics: interactions with cholinergic systems. , 1969, The Journal of pharmacology and experimental therapeutics.